James T. Glover, SVP, Operations and CFO at ANADYS PHARMACEUTICALS INC (ANDS), bought 4,170 shares at $3.45 ($14K) on 2007-02-28, disclosed to the SEC on 2007-03-02.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.45 | 1,000 | $3K | 24.0% |
| 2 | $3.45 | 3,170 | $11K | 76.0% |
| Total | $3.45 avg | 4,170 | $14K | 100% |
| Filing → |
| ANDS | BUY | 2007-11-19 | $4K | — | Filing → |
| ANDS | BUY | 2007-11-13 | $11K | — | Filing → |
| ANDS | BUY | 2007-08-16 | $2K | — | Filing → |